Phreesia, Inc. (NYSE:PHR) Short Interest Update

Phreesia, Inc. (NYSE:PHR - Get Free Report) saw a significant decrease in short interest in February. As of February 28th, there was short interest totalling 2,060,000 shares, a decrease of 17.6% from the February 13th total of 2,500,000 shares. Based on an average trading volume of 412,300 shares, the short-interest ratio is currently 5.0 days. Currently, 3.8% of the shares of the company are short sold.

Phreesia Stock Down 0.6 %

Shares of NYSE:PHR traded down $0.16 during midday trading on Friday, hitting $27.45. 542,368 shares of the company's stock traded hands, compared to its average volume of 416,802. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74. The company has a market cap of $1.61 billion, a PE ratio of -18.68 and a beta of 1.03. The firm's fifty day moving average price is $27.33 and its two-hundred day moving average price is $24.07. Phreesia has a twelve month low of $17.07 and a twelve month high of $30.53.

Insider Transactions at Phreesia

In other news, SVP Amy Beth Vanduyn sold 1,311 shares of the stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $26.61, for a total transaction of $34,885.71. Following the completion of the sale, the senior vice president now owns 115,633 shares in the company, valued at approximately $3,076,994.13. This represents a 1.12 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, COO Evan Roberts sold 2,873 shares of the stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $26.61, for a total transaction of $76,450.53. Following the sale, the chief operating officer now owns 779,993 shares of the company's stock, valued at $20,755,613.73. This trade represents a 0.37 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 162,442 shares of company stock worth $4,611,300. Company insiders own 5.80% of the company's stock.

Remove Ads

Institutional Investors Weigh In On Phreesia

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its position in shares of Phreesia by 1.3% during the 4th quarter. Vanguard Group Inc. now owns 4,823,110 shares of the company's stock valued at $121,349,000 after buying an additional 61,048 shares during the last quarter. Greenhouse Funds LLLP grew its position in shares of Phreesia by 27.9% during the 4th quarter. Greenhouse Funds LLLP now owns 2,873,892 shares of the company's stock valued at $72,307,000 after buying an additional 626,579 shares during the last quarter. Champlain Investment Partners LLC grew its position in shares of Phreesia by 4.1% during the 3rd quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company's stock valued at $57,062,000 after buying an additional 97,847 shares during the last quarter. Franklin Resources Inc. grew its position in shares of Phreesia by 0.8% during the 4th quarter. Franklin Resources Inc. now owns 1,509,617 shares of the company's stock valued at $37,982,000 after buying an additional 11,986 shares during the last quarter. Finally, State Street Corp grew its position in shares of Phreesia by 7.1% during the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company's stock valued at $30,256,000 after buying an additional 88,517 shares during the last quarter. Hedge funds and other institutional investors own 92.10% of the company's stock.

Wall Street Analyst Weigh In

PHR has been the subject of a number of recent research reports. Needham & Company LLC reissued a "buy" rating and set a $29.00 price objective on shares of Phreesia in a research note on Thursday, March 13th. KeyCorp lifted their target price on shares of Phreesia from $28.00 to $30.00 and gave the stock an "overweight" rating in a research note on Wednesday, January 8th. Canaccord Genuity Group lifted their target price on shares of Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a research note on Thursday, March 13th. JMP Securities reaffirmed a "market outperform" rating and issued a $30.00 target price on shares of Phreesia in a research note on Tuesday, December 10th. Finally, Robert W. Baird lowered their target price on shares of Phreesia from $34.00 to $30.00 and set an "outperform" rating for the company in a research note on Wednesday, December 11th. Twelve investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock presently has a consensus rating of "Buy" and an average price target of $31.33.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.